LLY
Stocks
1,169.60
$1T mkt cap
Chart
Trend
1d
Bear
29d 17h
+4.07% — to line
Flipped
1w
Bull
at least 95d 2h
+5.06% — to line
Flipped
About
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
Flip history
Earnings history
| Quarter ending | EPS | Consensus | Surprise |
|---|---|---|---|
| 2026-06-30 | 8.38 | 6.58 | +27.3% |
| 2026-03-31 | 8.55 | 6.79 | +25.9% |
| 2025-12-31 | 7.54 | 6.91 | +9.1% |
| 2025-09-30 | 7.02 | 5.89 | +19.1% |
Reported results against analyst consensus, newest first – the last 4 quarters on file. Dates are the fiscal quarter's end, not the announcement. No forward estimate appears here.